Zai Lab Presents Positive Phase 1 Data For Zl-1310, A Dll3-Targeted Adc
RefinitivMenos de 1 minuto de lectura
Zai Lab Ltd 
9688:
ZAI LAB PRESENTS POSITIVE PHASE 1 DATA FOR ZL-1310, A DLL3-TARGETED ADC, DEMONSTRATING ROBUST ANTI-TUMOR ACTIVITY AND SAFETY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER AT 2025 ASCO ANNUAL MEETING
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia